Comparison of the Incidence of Major Bleeding with Rivaroxaban Use among Nonvalvular Atrial Fibrillation Patients With versus Without Diabetes Mellitus by Peacock, W. Frank, MD, Tamayo, Sally, CAPT, Sicignano, Nicholas, MPH, Hopf, Kathleen P., MPH, Yuan, Zhong, MD, PhD, Patel, Manesh, MD

Get full text

CHA2 DS2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban by Peacock, W. Frank, MD, Tamayo, Sally, CAPT, Patel, Manesh, MD, Sicignano, Nicholas, MPH, Hopf, Kathleen P., MPH, Yuan, Zhong, MD, PhD

Get full text

Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation by Tamayo, Sally G., MD, Simeone, Jason C., PhD, Nordstrom, Beth L., PhD, MPH, Patel, Manesh R., MD, Yuan, Zhong, MD, PhD, Sicignano, Nicholas M., MPH, Peacock, W. Frank, MD

Get full text